Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Myrexis Inc.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Histologically proven WHO Grade IV glioblastoma multiforme at time of diagnosis or relapse
Prior treatment with radiotherapy and temozolomide
Evidence of measurable recurrent or residual primary tumor by contrast-enhanced MRI
Be a minimum of 4 weeks since prior surgical resection, major surgical procedure, radiation therapy or cytotoxic chemotherapy (6 weeks since prior BCNU or CCNU)
Have a Performance Scale of Karnofsky \> 60%, ECOG \< 2 or WHO \< 2
If steroids are needed, be on a stable or decreasing dose of steroids for at least 1 week
You may not be if
Hypersensitivity to Cremophor EL
Have evidence of current/active intratumor hemorrhage by MRI
Have greater than second relapse
Have had prior treatment with platinum-based chemotherapy
